The ESCMID Study Group for Viral Hepatitis (ESGVH) is deeply committed to advancing knowledge on viral hepatitis. Uniting members from all over the globe, they are dedicated to:
ESGVH Newsletter, December 2025
ESGVH Newsletter, October 2025
ESGVH Newsletter, June 2025
ESGVH Newsletter, April 2025
ESGVH Newsletter, February 2025
ESGVH Newsletter, December 2024
ESGVH Newsletter, October 2024
ESGVH Newsletter, May 2024
ESGVH Newsletter, April 2024
When metabolic dysfunction-associated steatotic liver disease meets viral hepatitis
Imran Hasanoglu, Antonio Rivero-Juárez, Gülşen Özkaya Şahin, and ESCMID Study Group for Viral Hepatitis (ESGVH). J Clin Med. 2025;14(10):3422.
Achieving global immunity against hepatitis A through universal vaccination: A position paper from the European Society of Clinical Microbiology and Infectious Diseases Study Group for Viral Hepatitis (ESGVH)
Oana Săndulescu, Stefania Mantovani, Anne-Marie Roque-Afonso, Gülsen Özkaya Sahin, Asha K. Rajan, Mustafa Altındiş, Daniel Miron, Sertaç Küçükkaya, Mario U. Mondelli, and on behalf of ESGVH. Clinical Microbiology and Infection; 2025. November 2025
Global hepatitis C elimination: Updates, challenges, and opportunities from real-world experiences in Europe and North America
Oana Săndulescu, Susanne Gjeruldsen Dudman, Ivana Gmizic, Federico Garcia, Heli Harvala, Imran Hasanoglu, Naveed Z. Janjua, Justyna Kowalska, Vincent Mallet, Mojca Maticic, Mario U. Mondelli, Eline L.M. Op de Coul, Ponni V. Perumalswami, Gülşen Özkaya Şahin, Zeinab Said, Juan Francisco Sánchez-Avila, Petar Velikov, Nina Weis, Snjezana Zidovec-Lepej, Harrys A. Torres, on behalf of the Study Group for Viral Hepatitis of the European Society of Clinical Microbiology and Infectious Diseases (ESGVH) and the American Association for the Study of Liver Diseases (AASLD) Hepatitis C Special Interest Group. Hepatology; 2025:10.1097/HEP.0000000000001548
Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) – Part 1: hepatitis A, E, and herpesvirus-associated liver disease
Oana Săndulescu, Mojca Matičič, Federico Garcia, Marianne Alanko Blomé, Mario U Mondelli, William
Irving, Snjezana Zidovec-Lepej, Anders Widell, Gülşen Özkaya Şahin, and on behalf of ESCMID Study Group for
Viral Hepatitis (ESGVH). GERMS 15(3), September 2025, page 263
Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) – Part 2: hepatitis B, C, and delta
Oana Săndulescu, Mojca Matičič, Federico Garcia, Marianne Alanko Blomé, Mario U Mondelli, William
Irving, Snjezana Zidovec-Lepej, Anders Widell, Gülşen Özkaya Şahin, and on behalf of ESCMID Study Group for
Viral Hepatitis (ESGVH). GERMS 15(3), September 2025, page 263
Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group.
Dudman S, Zerja A, Hasanoğlu I, Ruta S, van Welzen B, Nicolini LA, Yonga P, Øverbø J, Rawat S, Habibovic S, Kim TB, Rivero-Juarez A; ESGVH members. Clin Microbiol Infect. 2025 Feb;31(2):201-210
Updates in viral hepatitis in 2024 – summary of education, research and leadership activities of the ESCMID Study Group for Viral Hepatitis (ESGVH).
Săndulescu O, Hasanoğlu İ, Matičič M. GERMS. 2024;14(4):320-321
Global vaccination against hepatitis E virus: position paper from the European society of clinical microbiology and infectious diseases viral hepatitis study group.
Dudman S, Zerja A, Hasanoğlu İ, Ruta S, van Welzen B, Nicolini LA, Yonga P, Øverbø J, Rawat S, Habibovic S, Kim TB, Rivero-Juarez A; ESGVH members. Clin Microbiol Infect. 2024 Nov 15:S1198-743X(24)00542-1.
The spectrum of esophagitis in patients living with HIV - a scoping review.
Olariu MC, Olariu MH, Iancu AM, Săndulescu O, Streinu-Cercel A, Barbu EC, Şahin GÖ, Borcan AM, Cruceru MM, Simoiu M; ESCMID Study Group for Viral Hepatitis (ESGVH). Germs. 2024 Jun 30;14(2):188-196
Communicable Episode 06: “Sneaky viruses”- an update on hepatitis B & C before World Hepatitis Day.
Hostettler, K, Matičič, M, Săndulescu, O, Huttner, A. CMI Communications. 2024; Volume 1, Issue 3, 105048
Exposure to biological fluids in dental practice – Narrative review on appropriate risk assessment to guide post-exposure management.
Săndulescu M, Nicolescu MI, Funieru C, Şahin GÖ, Săndulescu O and ESCMID Study Group for Viral Hepatitis (ESGVH). Pathogens. 2023;12(7):968.
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
Said ZNA, El Habashy SA, Zaky S and ESCMID Study Group for Viral Hepatitis (ESGVH). World J Gastroenterol. 2023;29(7):1123–1130.
AASLD/ESGVH Managing Complex Patients Not Eligible for Simplified Hepatitis C Treatment Webinar
16 October 2025, 16:00 CEST
Hepatitis E virus vaccination: Global perspectives, challenges, and pathways to implementation
02 June 2025, 15:00 - 17:00 CET
HBV and HCV management during pregnancy: focus on start and stop antivirals
24 April 2025 at 15:00 CET
AMM webinar on Atypical serological tests and their interpretation in Hepatitis B Viral infection
19 December 2024, 15:00-16:00 CET
Management of HBV and HCV in transplant patients
9 December 2024, 16:00 CET
Chair: İmran Hasanoglu
Speakers: Harrys Antonio Torres and Paolo Antonio Grossi
Hepatitis C Virus in Special and Vulnerable Populations
25 November 2024, 13:00-14:00 CET
Breaking the Wall on Hepatitis A and E Vaccination: Should we change current recommendations?
18 December 2023
If you have questions or comments for our study group, we warmly invite you to contact us!
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.
